Last Updated: 10 Jun 2025
Source: Statifacts
The global electronic data capture systems market size was estimated at USD 1,687 million in 2024 and is projected to be worth around USD 5,832 million by 2034, growing at a CAGR of 13.2% from 2025 to 2034.
| Industry Worth | Details |
| Market Size in 2025 | USD 1,915 Million |
| Market Size by 2034 | USD 5,832 Million |
| Market Growth Rate from 2025 to 2034 | CAGR of 13.2% |
Electronic data capture (EDC) system is a computerized system designed for the collection of clinical data in electronic format for use mainly in human clinical trials. EDC replaces the traditional paper-based data collection methodology to streamline data collection and expedite the time to market for drugs and medical devices. EDC enhances data accuracy, enhances data management, accelerates data collection and analysis, and ensures regulatory compliance. Rising demand for outsourcing clinical trials to CROs, increasing adoption of software solution in clinical trials, and increasing R&D spending driving the growth of the electronic data capture systems market.
Number of Clinical trials by country or area:
| Number of Clinical Trials | By Country |
| 186497 | United States of America |
| 135747 | China |
| 74031 | India |
| 69639 | Japan |
| 65167 | Germany |
AI and automation are used in electronic data capture (EDC) system to simplify study build, data capture, and clinical data management (CDM). Artificial intelligence (AI) and machine learning (ML) greatly improve EDC systems by automating data entry, identifying patterns, and predicting adverse events. These innovations enhance clinical trial accuracy and efficiency. Machine learning (ML) models analyze large datasets to optimize trial design and uncover hidden trends. AI based systems can automatically collect data from digital wearables like glucose or heart rate monitors, and synchronize this information directly with the EDC system.
Dr. Derk Arts, CEO of Castor, said, “After supporting 100s of COVID studies pro-bono, it was time to broaden our scope and leverage Castor’s platform to support all communities and innovations that need help fighting the global disease burden.” “The Castor for Impact Program is our commitment to making evidence-based medicine more accessible.”
Richard Staub, president of Research & Development Solutions at IQVIA said, “We are excited to announce our collaboration with SCRI Development Innovations.” “This collaboration embodies our commitment to innovation, efficiency, and delivering of superior outcomes for patients by bringing together the best of both organizations and eliminating the complexities often associated with multiple vendors. Together we will accelerate the development of new cancer therapies and improve outcomes for patients worldwide.”
North America held a significant share of the electronic data capture systems market in 2024. Rising demand for outsourcing clinical trials to CROs, rising adoption of software solution in clinical trials, and increasing R&D spending driving the growth of the market in the North American region.
Asia Pacific is projected to host the fastest growing market in the coming years. Increasing investment in R&D across sectors, digitization in manufacturing, the integration of smart technologies, and increased demand for sustainable products which contributing to the growth of the electronic data capture systems market in the Asia Pacific regions.
Over 170 countries where it operates. It operates in the cybersecurity, digital workplace, mobile, IT infrastructure, Internet of Things (IoT), data & analytics, commerce, artificial intelligence (AI), and cloud computing sectors around the world.
It operates in over 100 countries. It operates in the life sciences and healthcare sectors, around the world.
Published by Yogesh Kulkarni
